CTIS2023-507907-73-00进行中（未招募）1 期
nravelling intestinal fibrosis in ulcerative colitis: INTERACT study
Amsterdam UMC0 个研究点目标入组 10 人开始时间: 2023年9月8日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Adults =18 years with confirmed diagnosis of ulcerative colitis - Active disease confirmed by endoscopy (endoscopic Mayo score = 2) - Indication to start treatment with filgotinib AND one of the following: - Active disease confirmed by intestinal ultrasound (BWT > 3 mm in atleast one bowel segment and atleast one other pathological IUS parameter) or - Increased CRP (>5 mg/L) and/or fecal calprotectin levels (>250 mg/kg)
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study: - Pregnancy - Unable to provide informed consent - Colorectal carcinoma or high grade dysplasia
研究者
相似试验
尚未招募
不适用
Assessing mucosal inflammation in ulcerative colitis patients using the new Optical Enhancement Magnification Colonoscopeulcerative colitisACTRN12617000516381Concord Hospital120
招募中
Unknown
Development of Ulcerative Colitis-Associated Colorectal Cancers -A Prospective Case Registry Studylcerative colitisJPRN-UMIN000049021Fukuoka University Chikushi Hospital300
尚未招募
不适用
Mucosal biofilms in ulcerative colitisK51Ulcerative colitisDRKS00011090Medizinische Universität Wien25
招募中
2 期
Unravelling Intestinal Fibrosis in Ulcerative ColitisUlcerative Colitis (UC)Inflammatory Bowel Disease (IBD)Fibroblast Activation Protein InhibitorNCT06604273Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10
尚未招募
2 期
The etiopathogenesis of ulcerative colitis and its management by Ayurvedic treatmentCTRI/2021/02/031559Institute of Medical Sciences Banaras Hindu University